Using a special scan to find scar tissue in Crohn's disease
Part of Digestive system clinical trials.
This study uses a special imaging tracer (FAPI) to find scar tissue in the small intestine of people with Crohn's disease. The goal is to see if this scan can help doctors better understand which parts of the intestine are scarred, which may guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease that affects the last part of your small intestine (the ileum) or the area where a surgery was done before.
- You are about to start a biologic medicine for your Crohn's disease.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have very poor kidney function (eGFR under 30) or a known allergy to the contrast dye used in scans.
- You can lie still in a scanner for the PET/MRI or PET/CT and do not have claustrophobia or a metal implant that prevents MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new imaging method that uses a special PET/MR scan to see how active Crohn's disease is in your bowel. The scan uses a harmless radioactive tracer that attaches to scar tissue, which may help doctors better understand the disease and guide treatment.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
This study looks at how Crohn’s disease healing shows up on a special MRI (MRE) and tries to better define what “healed” means. It may help your care team track healing more accurately, especially inside the bowel.
This study uses a computer program to look at scar tissue in biopsy samples from people with Crohn's disease. The goal is to see if the amount of scar tissue is linked to patient history and how the disease progresses over time.
This study tests a new PET scan with a tracer called 68Ga-FAPI-46 to see how well it can find and measure scarring (fibrosis) in the small bowel caused by Crohn's disease. It may help doctors better understand and manage bowel damage.
This trial tests a new type of PET scan to see if it can accurately spot inflamed or damaged areas in the intestines of people with inflammatory bowel disease (IBD). If it works, it could help doctors track disease activity without relying only on invasive tests.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.